VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis

Takaaki Fujii, Yoshikazu Yonemitsu, Mitsuho Onimaru, Makoto Inoue, Mamoru Hasegawa, Hiroyuki Kuwano, Katsuo Sueishi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is a major positive angiogenic factor. Using a murine hindlimb ischemia model, we previously showed that fibroblast growth factor-2 (FGF-2) enhances the expression of endogenous VEGF which highly contribute to the therapeutic effect of FGF-2 gene transfer. Recently, placental growth factor (PlGF) has been shown to play an important role in angiogenesis. However, the molecular mechanism of endogenous PlGF during FGF-2-mediated angiogenesis has not been elucidated. Severe hindlimb ischemia stimulated PlGF expression that was more strongly enhanced by FGF-2 gene transfer, and a blockade of PlGF activity diminished the recovery of blood flow by FGF-2-mediated angiogenesis. The PlGF expression in cultured endothelial cells was significantly enhanced by VEGF stimulation, but not by FGF-2. The upregulation of endogenous PlGF expression was significantly decreased by the inhibition of endogenous VEGF activity in vivo. Subsequent signal inhibition experiments revealed that the PKC, MEK, and possibly NF-κB-related pathways were essential in stimulating PlGF expression with VEGF, while p70S6K is the regulator for VEGF expression. These results indicate that the FGF-2-mediated enhancement of PlGF expression was dependent on VEGF function, and the FGF-2/VEGF axis participates in FGF-2-mediated angiogenesis indirectly via PlGF as well as directly.

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalAtherosclerosis
Volume200
Issue number1
DOIs
Publication statusPublished - Sep 1 2008
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 2
Vascular Endothelial Growth Factor A
Intercellular Signaling Peptides and Proteins
Up-Regulation
Therapeutics
Hindlimb
Ischemia
70-kDa Ribosomal Protein S6 Kinases
Angiogenesis Inducing Agents
Mitogen-Activated Protein Kinase Kinases
Therapeutic Uses
Genes
Cultured Cells
Endothelial Cells

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis. / Fujii, Takaaki; Yonemitsu, Yoshikazu; Onimaru, Mitsuho; Inoue, Makoto; Hasegawa, Mamoru; Kuwano, Hiroyuki; Sueishi, Katsuo.

In: Atherosclerosis, Vol. 200, No. 1, 01.09.2008, p. 51-57.

Research output: Contribution to journalArticle

Fujii, Takaaki ; Yonemitsu, Yoshikazu ; Onimaru, Mitsuho ; Inoue, Makoto ; Hasegawa, Mamoru ; Kuwano, Hiroyuki ; Sueishi, Katsuo. / VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis. In: Atherosclerosis. 2008 ; Vol. 200, No. 1. pp. 51-57.
@article{a7bce283d28245d782b4f3ea2a0840ed,
title = "VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis",
abstract = "Vascular endothelial growth factor (VEGF) is a major positive angiogenic factor. Using a murine hindlimb ischemia model, we previously showed that fibroblast growth factor-2 (FGF-2) enhances the expression of endogenous VEGF which highly contribute to the therapeutic effect of FGF-2 gene transfer. Recently, placental growth factor (PlGF) has been shown to play an important role in angiogenesis. However, the molecular mechanism of endogenous PlGF during FGF-2-mediated angiogenesis has not been elucidated. Severe hindlimb ischemia stimulated PlGF expression that was more strongly enhanced by FGF-2 gene transfer, and a blockade of PlGF activity diminished the recovery of blood flow by FGF-2-mediated angiogenesis. The PlGF expression in cultured endothelial cells was significantly enhanced by VEGF stimulation, but not by FGF-2. The upregulation of endogenous PlGF expression was significantly decreased by the inhibition of endogenous VEGF activity in vivo. Subsequent signal inhibition experiments revealed that the PKC, MEK, and possibly NF-κB-related pathways were essential in stimulating PlGF expression with VEGF, while p70S6K is the regulator for VEGF expression. These results indicate that the FGF-2-mediated enhancement of PlGF expression was dependent on VEGF function, and the FGF-2/VEGF axis participates in FGF-2-mediated angiogenesis indirectly via PlGF as well as directly.",
author = "Takaaki Fujii and Yoshikazu Yonemitsu and Mitsuho Onimaru and Makoto Inoue and Mamoru Hasegawa and Hiroyuki Kuwano and Katsuo Sueishi",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.atherosclerosis.2007.12.012",
language = "English",
volume = "200",
pages = "51--57",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis

AU - Fujii, Takaaki

AU - Yonemitsu, Yoshikazu

AU - Onimaru, Mitsuho

AU - Inoue, Makoto

AU - Hasegawa, Mamoru

AU - Kuwano, Hiroyuki

AU - Sueishi, Katsuo

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Vascular endothelial growth factor (VEGF) is a major positive angiogenic factor. Using a murine hindlimb ischemia model, we previously showed that fibroblast growth factor-2 (FGF-2) enhances the expression of endogenous VEGF which highly contribute to the therapeutic effect of FGF-2 gene transfer. Recently, placental growth factor (PlGF) has been shown to play an important role in angiogenesis. However, the molecular mechanism of endogenous PlGF during FGF-2-mediated angiogenesis has not been elucidated. Severe hindlimb ischemia stimulated PlGF expression that was more strongly enhanced by FGF-2 gene transfer, and a blockade of PlGF activity diminished the recovery of blood flow by FGF-2-mediated angiogenesis. The PlGF expression in cultured endothelial cells was significantly enhanced by VEGF stimulation, but not by FGF-2. The upregulation of endogenous PlGF expression was significantly decreased by the inhibition of endogenous VEGF activity in vivo. Subsequent signal inhibition experiments revealed that the PKC, MEK, and possibly NF-κB-related pathways were essential in stimulating PlGF expression with VEGF, while p70S6K is the regulator for VEGF expression. These results indicate that the FGF-2-mediated enhancement of PlGF expression was dependent on VEGF function, and the FGF-2/VEGF axis participates in FGF-2-mediated angiogenesis indirectly via PlGF as well as directly.

AB - Vascular endothelial growth factor (VEGF) is a major positive angiogenic factor. Using a murine hindlimb ischemia model, we previously showed that fibroblast growth factor-2 (FGF-2) enhances the expression of endogenous VEGF which highly contribute to the therapeutic effect of FGF-2 gene transfer. Recently, placental growth factor (PlGF) has been shown to play an important role in angiogenesis. However, the molecular mechanism of endogenous PlGF during FGF-2-mediated angiogenesis has not been elucidated. Severe hindlimb ischemia stimulated PlGF expression that was more strongly enhanced by FGF-2 gene transfer, and a blockade of PlGF activity diminished the recovery of blood flow by FGF-2-mediated angiogenesis. The PlGF expression in cultured endothelial cells was significantly enhanced by VEGF stimulation, but not by FGF-2. The upregulation of endogenous PlGF expression was significantly decreased by the inhibition of endogenous VEGF activity in vivo. Subsequent signal inhibition experiments revealed that the PKC, MEK, and possibly NF-κB-related pathways were essential in stimulating PlGF expression with VEGF, while p70S6K is the regulator for VEGF expression. These results indicate that the FGF-2-mediated enhancement of PlGF expression was dependent on VEGF function, and the FGF-2/VEGF axis participates in FGF-2-mediated angiogenesis indirectly via PlGF as well as directly.

UR - http://www.scopus.com/inward/record.url?scp=49749102835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749102835&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2007.12.012

DO - 10.1016/j.atherosclerosis.2007.12.012

M3 - Article

C2 - 18258238

AN - SCOPUS:49749102835

VL - 200

SP - 51

EP - 57

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -